Press releases
Apollon Announces Joint Venture With Tri-Medi Canna In South Africa
Apollon Formularies plc (AQSE: APOL, “Apollon” or the “Company”), a UK based internationalpharmaceutical company trading on the Aquis Stock Exchange, is pleased to announce that it hassigned a Joint Venture Agreement (the “Joint Venture”) with Tri-Medi Canna Pty Ltd. (“Tri-MediCanna”), a South African based medical cannabis company, to establish a jointly-owned incorporatedSouth African company, Apollon…